전문 번역가, 번역 회사, 웹 페이지 및 자유롭게 사용할 수 있는 번역 저장소 등을 활용합니다.
exjade deferasirox
exjade deferasiroxum
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
the active substance is deferasirox.
léčivou látkou je deferasiroxum.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
description of available deferasirox formulations
popis dostupných lékových forem deferasiroxu
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
exjade 500 mg dispersible tablets deferasirox
exjade 500 mg tablety pro přípravu perorální suspenze deferasiroxum
마지막 업데이트: 2012-04-11
사용 빈도: 6
품질:
deferasirox metabolism depends on ugt enzymes.
metabolismus deferasiroxu je závislý na ugt enzymech.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
each dispersible tablet contains 125 mg deferasirox.
jedna tableta pro přípravu perorální suspenze obsahuje deferasiroxum 125 mg.
마지막 업데이트: 2012-04-11
사용 빈도: 4
품질:
exjade 180 mg film-coated tablets deferasirox
exjade 180 mg potahované tablety deferasiroxum
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
each dispersible tablet contains 125 mg of deferasirox.
jedna tableta pro přípravu perorální suspenze obsahuje 125 mg deferasiroxum.
마지막 업데이트: 2012-04-11
사용 빈도: 6
품질:
deferasirox (used to reduce chronic iron overload)
deferasirox (užívaný ke snížení chronického přetížení železem)
마지막 업데이트: 2017-04-26
사용 빈도: 4
품질:
each film-coated tablet contains 180 mg deferasirox.
jedna potahovaná tableta obsahuje deferasiroxum 180 mg.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
each tablet of exjade 250 mg contains 250 mg deferasirox.
1 tableta přípravku exjade 250 mg obsahuje 250 mg deferasiroxum.
마지막 업데이트: 2012-04-11
사용 빈도: 6
품질:
deferasirox promotes excretion of iron, primarily in the faeces.
deferasirox podporuje vylučování železa, a to převážně do stolice.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
that deferasirox causes rises in serum creatinine in some patients
informaci, že deferasirox způsobuje u některých pacientů zvýšení sérového kreatininu
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
deferasirox did not cause other effects on fertility or reproduction.
deferasirox neměl jiné účinky na fertilitu nebo reprodukci.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
no inhibition of deferasirox metabolism by hydroxyurea was observed in vitro.
inhibice metabolismu deferasiroxu hydroxyureou nebyla in vitro pozorována.
마지막 업데이트: 2012-04-11
사용 빈도: 2
품질:
each film-coated tablet of exjade 180 mg contains 180 mg deferasirox.
1 potahovaná tableta přípravku exjade 180 mg obsahuje deferasiroxum 180 mg.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
the active substance in exjade, deferasirox, is an ‘iron chelator’.
léčivá látka v přípravku exjade, deferasirox, je „chelátor železa“.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
an interaction between deferasirox and other cyp2c8 substrates like paclitaxel cannot be excluded.
nelze vyloučit interakci deferasiroxu a jiných substrátů cyp2c8 jako paklitaxelu.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
exjade 125 mg dispersible tablets exjade 250 mg dispersible tablets exjade 500 mg dispersible tablets deferasirox
exjade 125 mg dispergovatelné tablety exjade 250 mg dispergovatelné tablety exjade 500 mg dispergovatelné tablety deferasiroxum
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
exjade 90 mg film-coated tablets exjade 180 mg film-coated tablets exjade 360 mg film-coated tablets deferasirox
exjade 90 mg potahované tablety exjade 180 mg potahované tablety exjade 360 mg potahované tablety deferasiroxum
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질: